Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The essentially different pharmacodynamic response to colchicine of benign and of malignant epidermal hyperplasia in skin-tumor-resistant RA mice

  • 13 Accesses

  • 7 Citations

This is a preview of subscription content, log in to check access.

Literatur

  1. 1a)

    Setälä, K. Acta Pathol. Microbiol. Scand.26, 682 (1949).

  2. 1b)

    : Progr. Exp. Tumor Res.1, 225 (1960);

  3. 1c)

    Setälä, K.: Res. Commun. X. Int. Congr. Radiol., Montreal, Canada 1962;

  4. 1d)

    Setälä, K. Acta Pathol. Microbiol. Scand. [Edit.] Suppl. 155 (1962).

  5. 1e)

    Setälä, K. Progr. Exp. Tumor Res.5 (in press).

  6. 2)

    Setälä, K., B. Lindroos, u.O. Nyyssönen: Strahlentherapie121, 96 (1963);122, 565 (1963);123, 99 (1964).

  7. 3)

    Setälä, K., B. Lindroos u.A. Hujanen: Naturwissenschaften50, 45 (1963).

  8. 4)

    Setälä, K., u.O. Nyyssönen: Naturwissenschaften51 (in press).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Setälä, K. The essentially different pharmacodynamic response to colchicine of benign and of malignant epidermal hyperplasia in skin-tumor-resistant RA mice. Naturwissenschaften 51, 245–246 (1964). https://doi.org/10.1007/BF00641373

Download citation

Keywords

  • Colchicine
  • Pharmacodynamic Response
  • Epidermal Hyperplasia